Last reviewed · How we verify
NCT03598101: TONFITreha
TONEFITreha: Proof of Concept and Usability Study.
NA trial testing TONEFITreha in Neurological Disorder in 9 participants. Completed in 30 November 2019.
30 May 2019
Quick facts
| Lead sponsor | Reha Rheinfelden |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 9 |
| Start date | 1 December 2018 |
| Primary completion | 30 May 2019 |
| Estimated completion | 30 November 2019 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- TONEFITreha
Conditions studied
- Neurological Disorder — all drugs for Neurological Disorder →
- Orthopedic Disorder — all drugs for Orthopedic Disorder →
Sponsor
Reha Rheinfelden — full company profile →
Who can join
18 and older, any sex, with Neurological Disorder or Orthopedic Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The importance of physical activity and exercise-based interventions in neuro-orthopaedic rehabilitation is undisputed. Yet, patients and clinicians do not implement minimally required doses of physical activity in standard rehabilitation programs. This is partly due to intrinsic factors such as motivation, or due to physical condition that prevent any kind of exercise. In most cases, however, it is owed to limited time spent with therapists who would be able to supervise and apply the required doses to induce any potential exercise effects. Methods to semi-autonomously exercise with high motivation and continuous feedback would complement existing therapies and allow adherence to minimal dose recommendations. For this study, a prototype of a new portable training solution for intensive walking exercise with built-in sensor-technology and a smartphone interface will be tested regarding its usability and its efficiency in a clinical setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03598101
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neurological Disorder
Currently open trials in the same condition.
- NCT07456475 — Metaverse Applications in Clinical Neurorehabiliation: Device Feasibility · NA · active not recruiting
- NCT05106725 — Wearable Devices and Biomarkers Project (Healthiomics) · recruiting
- NCT06278961 — Families Filming Infants Learning Movement · recruiting
- NCT04436068 — Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging · NA · active not recruiting
- NCT04368481 — MIDI (MR Imaging Abnormality Deep Learning Identification) · recruiting
Other Reha Rheinfelden trials
Trials by the same sponsor.
- NCT03268304 — Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03598101 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Reha Rheinfelden
- Last refreshed: 21 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03598101.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing